Form 3CRSPCIK 0001674416
CRISPR Therapeutics AG
Initial insider ownership (Form 3) filed .
Initial statement of beneficial ownership filed by a company's officers, directors, and 10%+ owners when they first become an insider.
Filing facts
- Accession number
- 0000950170-24-065202
- Filer
- CRISPR Therapeutics AG
- Ticker
- CRSP
- CIK
- 0001674416
- Form type
- Form 3
- Form description
- Initial insider ownership
- Filed at
- May 28, 2024
- Period of report
- 2024-05-28
- Industry
- SIC 2836Biological Products
- Filing size
- 18.4 KB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1674416/000095017024065202/0000950170-24-065202-index.htm ↗Filer's full EDGAR submission history
EDGAR · CRISPR Therapeutics AG (0001674416) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0000950170-24-065202.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.